1. Home
  2. RYI vs CRMD Comparison

RYI vs CRMD Comparison

Compare RYI & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryerson Holding Corporation

RYI

Ryerson Holding Corporation

HOLD

Current Price

$25.78

Market Cap

843.2M

Sector

Industrials

ML Signal

HOLD

Logo CorMedix Inc.

CRMD

CorMedix Inc.

HOLD

Current Price

$12.75

Market Cap

943.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYI
CRMD
Founded
1842
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
843.2M
943.9M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
RYI
CRMD
Price
$25.78
$12.75
Analyst Decision
Hold
Strong Buy
Analyst Count
1
7
Target Price
$25.00
$17.43
AVG Volume (30 Days)
359.7K
2.6M
Earning Date
10-28-2025
11-12-2025
Dividend Yield
2.85%
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.25
Revenue
$4,473,900,000.00
$214,303,672.00
Revenue This Year
$0.38
$627.89
Revenue Next Year
$4.72
$40.95
P/E Ratio
N/A
$5.56
Revenue Growth
N/A
1647.67
52 Week Low
$17.18
$5.60
52 Week High
$27.41
$17.43

Technical Indicators

Market Signals
Indicator
RYI
CRMD
Relative Strength Index (RSI) 61.69 68.80
Support Level $23.57 $11.78
Resistance Level $26.60 $12.51
Average True Range (ATR) 0.92 0.50
MACD 0.08 0.14
Stochastic Oscillator 75.98 96.65

Price Performance

Historical Comparison
RYI
CRMD

About RYI Ryerson Holding Corporation

Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. Its customers range from local, independently owned fabricators and machine shops to large, international original equipment manufacturers. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company generates substantially all of its revenue from sales of metal products. Geographically, the majority revenue is generated from the United States.

About CRMD CorMedix Inc.

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.

Share on Social Networks: